Funding news for global health researchers: November 25, 2024

On behalf of the Fogarty International Center at the U.S. National Institutes of Health (NIH), the following funding opportunities, notices and announcements may be of interest to those working in the field of global health research. Updates are typically distributed once a week.

Special Announcements

Upcoming Webinar: Learning From Global Food and Nutrition Insecurity

The upcoming Learning From Global Food and Nutrition Insecurity Across Borders webinar will launch the Global Food and Nutrition Security Research supplement recently published in Frontiers. The webinar will explore innovative strategies and best practices across the life course to understand the determinants of and effectively address food and nutrition insecurity across national and international contexts.

• Webinar date: December 3, 2024, 11:00 a.m. EST (USA)
• Register for webinar
• More Information

Fogarty-partnered NIMHD Research Training Program Now Accepting Applications

The NIMHD Minority Health and Health Disparities Research Training (MHRT) Program supports research training activities that are consistent with the mission of NIMHD. The program helps ensure that a diverse pool of highly trained scientists is available in appropriate scientific disciplines to address the Nation's need to advance scientific research to improve minority health and reduce health disparities.

• Applications due date: January 10, 2025
• Read funding opportunity (RFA-MD-25-001)

NIH Interested in Implementation Science for Climate Change and Health

The NIH Climate Change and Health Initiative (CCHI), an urgent, cross-cutting NIH effort to stimulate research to reduce health threats from climate change across the lifespan, is seeking applications that propose implementation studies to understand and address barriers and facilitators to the adoption, implementation, scale-up, and sustainment of effective interventions to prevent or mitigate the health effects of climate change in the United States and globally.

• Applications due date: February 5, 2025
• Read Notice of Special Interest (NOT-CA-25-003)

Upcoming Deadlines for Fogarty Funding Opportunities

• Emerging Global Leader Award
  Application deadline: December 3, 2024
  
• Global Brain Disorders Research (AIDS)
  Application deadline: December 9, 2024
  
• HIV-associated Noncommunicable Diseases Research at LMIC Institutions
  Application deadline: December 9, 2024
  

Upcoming deadlines for all Fogarty funding opportunities

Funding opportunities on which Fogarty is a partner:

• Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed) (PAR-25-233)
  Application due date: Multiple dates, see announcement.
• Dissemination and Implementation Research in Health (R21 Clinical Trial Optional) (PAR-25-143)
  Application due date: Multiple dates, see announcement.

Administrative supplements for current Fogarty grant recipients:

• Administrative Supplement for Research and Capacity Building Efforts Related to Bioethical Issues (Admin Supp Clinical Trial Optional) (NOT-OD-25-015) 
  Expiration date: January 24, 2025
  
• Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) (PA-20-272) 
  Expiration date: January 24, 2025
  
• Administrative Supplement for Continuity of Biomedical and Behavioral Research Among First-Time Recipients of NIH Research Project Grant Awards (NOT-OD-23-032) 
  Expiration date: October 1, 2025
  
• Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) (PA-23-189) 
  Expiration date: May 8, 2026
  

All administrative supplements

Funding Opportunities

NIH funding opportunities focusing on global health and foreign collaboration:

• Integrating Mental Health Care into Health Care Systems and Non-Health Settings in Low- and Middle-Income Countries (R01 Clinical Trial Optional) (PAR-25-201)
  Application due date: Multiple dates, see announcement.
• Career Development Opportunities for Research on Cancer in Global Settings at the Center for Global Health at the National Cancer Institute  (NOT-CA-24-098)
  Application due date: Multiple dates, see announcement.
• Small Research Grant Program for the Next Generation of Researchers in Low- and Middle-Income Countries (LMICs) for Aging and Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) Research (R03 Clinical Trial Not Allowed) (RFA-AG-25-031)
  Application due date: Multiple dates, see announcement.
• Consortium for Neuroscience AD/ADRD in Low- and Middle-Income Countries (U01 Clinical Trial Not Allowed) (RFA-AG-25-032)
  Application due date: Multiple dates, see announcement.

More NIH funding opportunities focused on areas relevant to global health

NIH funding opportunities for which foreign organizations and/or foreign components of U.S. organizations may apply:

• Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) (R21 Clinical Trial Not Allowed) (PA-25-173)
  Application due date: February 16, 2025
• Research Opportunities in Established Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed) (PAR-25-275)
  Application due date: February 28, 2025
• Advancing Translation of Long-Acting Strategies for HIV and HIV-Associated Co-infections (AT LASt) (R61/R33 Clinical Trial Not Allowed) (RFA-AI-24-076)
  Application due date: March 13, 2025
• Role of T-Cells in HIV CNS Reservoir Seeding, Persistence, and Neuropathogenesis funding opportunities:
  • R01 Clinical Trial Not Allowed (RFA-MH-26-110)
    Application due date: March 18, 2025
  • R21 Clinical Trial Not Allowed (RFA-MH-26-111)
    Application due date: March 18, 2025
• NIDA Avant-Garde Program for HIV and Substance Use Disorder Research (DP1 Clinical Trial Optional) (PAR-25-261)
  Application due date: August 15, 2025
• Contraceptive Development Research Centers (P50 Clinical Trial Optional) (RFA-HD-26-004)
  Application due date: November 12, 2025
• NICHD Small Research Grant Program funding opportunities:
  • R03 Clinical Trial Required (PA-25-125)
    Application due date: Multiple dates, see announcement.
  • R03 Basic Experimental Studies with Humans Required (PA-25-126)
    Application due date: Multiple dates, see announcement.
• Small Research Grant Program for the Next Generation of Researchers in AD/ADRD Research (R03 Clinical Trial Optional) (PA-25-246)
  Application due date: Multiple dates, see announcement.
• Novel Assays to Address Translational Gaps in Treatment Development (UG3/UH3 Clinical Trial Optional) (PAR-25-034)
  Application due date: Multiple dates, see announcement.
• Building in vivo Preclinical Assays of Circuit Engagement for Application in Therapeutic Development (R01 Clinical Trial Not Allowed) (PAR-25-035)
  Application due date: Multiple dates, see announcement.
• Cellular and Molecular Biology of Complex Brain Disorders funding opportunities:
  • R21 Clinical Trial Not Allowed (PAR-25-037)
    Application due date: Multiple dates, see announcement.
  • R21 Clinical Trial Optional (PAR-25-038)
    Application due date: Multiple dates, see announcement.
• Schizophrenia and related disorders during mid- to late-life funding opportunities:
  • R01 Clinical Trial Optional (PAR-25-039)
    Application due date: Multiple dates, see announcement.
  • R01 Clinical Trial Not Allowed (PAR-25-040)
    Application due date: Multiple dates, see announcement.
• Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia funding opportunities:
  • R21 Clinical Trial Optional (PAR-25-064)
    Application due date: Multiple dates, see announcement.
  • R01 Clinical Trial Optional (PAR-25-065)
    Application due date: Multiple dates, see announcement.
• Social disconnection and Suicide Risk in Late Life funding opportunities:
  • R21 Clinical Trial Optional (PAR-25-066)
    Application due date: Multiple dates, see announcement.
  • R01 Clinical Trial Optional (PAR-25-067)
    Application due date: Multiple dates, see announcement.
• Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics funding opportunities:
  • R01 Clinical Trial Optional (PAR-25-069)
    Application due date: Multiple dates, see announcement.
  • R21 Clinical Trial Not Allowed (PAR-25-070)
    Application due date: Multiple dates, see announcement.
• Impacts of climate change across the cancer control continuum (R01 Clinical Trial Optional) (PAR-25-094)
  Application due date: Multiple dates, see announcement.
• Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes funding opportunities:
  • R01 Clinical Trial Not Allowed (PAR-25-095)
    Application due date: Multiple dates, see announcement.
  • R21 Clinical Trials Not Allowed (PAR-25-096)
    Application due date: Multiple dates, see announcement.
• Small Research Grants for Analyses of Gabriella Miller Kids First Pediatric Research Data (R03 Clinical Trial Not Allowed) (PAR-25-109)
  Application due date: Multiple dates, see announcement.
• Translational Research in Maternal and Pediatric Pharmacology and Therapeutics funding opportunities:
  • R01 Clinical Trial Optional (PAR-25-110)
    Application due date: Multiple dates, see announcement.
  • R21 Clinical Trial Optional (PAR-25-111)
    Application due date: Multiple dates, see announcement.
• Advancement and Innovation in Measurement of Language Development and Predictors funding opportunities:
  • R01 Clinical Trial Not Allowed (PAR-25-112)
    Application due date: Multiple dates, see announcement.
  • R21 Clinical Trial Not Allowed (PAR-25-113)
    Application due date: Multiple dates, see announcement.
• NCMRR Early Career Research Award (R03 Clinical Trial Optional) (PAR-25-124)
  Application due date: Multiple dates, see announcement.
• Biology of Bladder Cancer funding opportunities:
  • R21 Clinical Trial Optional (PAR-25-128)
    Application due date: Multiple dates, see announcement.
  • R01 Clinical Trial Optional (PAR-25-129)
    Application due date: Multiple dates, see announcement.
• Impacts of climate change across the cancer control continuum (R21 Clinical Trial Optional) (PAR-25-152)
  Application due date: Multiple dates, see announcement.
• NIDCR Research Grants for Analyses of Existing Genomics Data (R01) (Clinical Trial Not Allowed) (PAR-25-164)
  Application due date: Multiple dates, see announcement.
• NIDCR Small Research Grants for Analyses of Existing Genomics Data (R03 Clinical Trial Not Allowed) (PAR-25-166)
  Application due date: Multiple dates, see announcement.
• Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional) (PAR-25-171)
  Application due date: Multiple dates, see announcement.
• Information and Practice Needs Relevant to Late Talking Children (R21 Clinical Trial Not Allowed) (PAR-25-217)
  Application due date: Multiple dates, see announcement.
• Leveraging Extant Data to Understand Developmental Trajectories of Late Talking Children (R21 Clinical Trial Not Allowed) (PAR-25-220)
  Application due date: Multiple dates, see announcement.
• Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required) (PAR-25-226)
  Application due date: Multiple dates, see announcement.
• Investigator Initiated Innovation in Computational Genomics and Data Science funding opportunities:
  • R01 Clinical Trial Not Allowed (PAR-25-228)
    Application due date: Multiple dates, see announcement.
  • R21 Clinical Trial Not Allowed (PAR-25-229)
    Application due date: Multiple dates, see announcement.
• Basic Research in Cancer Health Disparities funding opportunities:
  • R01 Clinical Trial Not Allowed (PAR-25-243)
    Application due date: Multiple dates, see announcement.
  • R21 Clinical Trial Not Allowed (PAR-25-244)
    Application due date: Multiple dates, see announcement.
• Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed) (PAR-25-248)
  Application due date: Multiple dates, see announcement.
• Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required) (PAR-25-254)
  Application due date: Multiple dates, see announcement.
• Mood and Psychosis Symptoms during the Menopause Transition funding opportunities:
  • R01 Clinical Trial Optional (PAR-25-281)
    Application due date: Multiple dates, see announcement.
  • R21 Clinical Trial Optional (PAR-25-282)
    Application due date: Multiple dates, see announcement.
• Neuromodulation/Neurostimulation Device Development for Mental Health Applications funding opportunities:
  • R21 Clinical Trial Not Allowed (PAR-25-286)
    Application due date: Multiple dates, see announcement.
  • R01 Clinical Trial Not Allowed (PAR-25-287)
    Application due date: Multiple dates, see announcement.
• Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders funding opportunities:
  • R01 Clinical Trial Optional (PAR-25-290)
    Application due date: Multiple dates, see announcement.
  • R21 Clinical Trial Optional (PAR-25-291)
    Application due date: Multiple dates, see announcement.
• Enhancing Reuse of NHGRI Data Assets (R03 Clinical Trial Not Allowed) (RFA-HG-25-005)
  Application due date: Multiple dates, see announcement.
• Catalyze funding opportunities:
  • Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed) (RFA-HL-26-016)
    Application due date: Multiple dates, see announcement.
  • Product Definition for Small Molecules, Biologics and Combination Products - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 – Clinical Trials Not Allowed) (RFA-HL-26-017)
    Application due date: Multiple dates, see announcement.
  • Product Definition for Small Molecules, Biologics, and Combination Products - Preliminary Product/Lead Series Identification and Combination Product Prototype (R33 - Clinical Trial Not Allowed) (RFA-HL-26-018)
    Application due date: Multiple dates, see announcement.
  • Product Definition – Medical Device prototype design/testing and disease target identification and assay development (R61/R33 - Clinical Trial Not Allowed) (RFA-HL-26-019)
    Application due date: Multiple dates, see announcement.
  • Product Definition – Medical Device Prototype Optimization (R33 - Clinical Trial Not Allowed) (RFA-HL-26-020)
    Application due date: Multiple dates, see announcement.
• Limited Competition: Competing Revisions to Support Clinical Trials in Somatic Cell Genome Editing (U19 Clinical Trial Required) (RFA-RM-24-008)
  Application due date: Multiple dates, see announcement.

NIH funding opportunities for which foreign components may apply:

• NINR Resources and Related Research Projects in Firearm Injury Prevention (R24 Clinical Trial Not Allowed) (RFA-NR-25-002)
  Application due date: January 28, 2025
• Advancing Genomic Medicine Research funding opportunities:
  • R01 Clinical Trial Optional (RFA-HG-25-002)
    Application due date: February 11, 2025
  • R03 Clinical Trial Not Allowed (RFA-HG-25-004)
    Application due date: February 11, 2025
• NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (UG3/UH3 Clinical Trial Optional) (PAR-25-052)
  Application due date: Multiple dates, see announcement.
• Pragmatic Trials across the Cancer Control Continuum (UG3/UH3 Clinical Trial Required) (PAR-25-072)
  Application due date: Multiple dates, see announcement.
• Advancing Research Careers (ARC) Predoctoral to Postdoctoral Transition Award to Promote Broad Participation (F99/K00 - Clinical Trial Not Allowed) (PAR-25-084)
  Application due date: Multiple dates, see announcement.
• Archiving and Documenting Child Health and Human Development Data Sets (R03 Clinical Trial Not Allowed) (PAR-25-092)
  Application due date: Multiple dates, see announcement.
• NIDCR Small Grant Program for New Investigators (R03 Clinical Trial Not Allowed) (PAR-25-105)
  Application due date: Multiple dates, see announcement.
• NCI Pathway to Independence Award (K99/R00 – Clinical Trial Not Allowed) (PAR-25-135)
  Application due date: Multiple dates, see announcement.
• Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required) (PAR-25-148)
  Application due date: Multiple dates, see announcement.
• NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed) (PAR-25-204)
  Application due date: Multiple dates, see announcement.
• NCCIH Multi-Site Feasibility Clinical Trials of Mind and Body Interventions (R01 Clinical Trial Required) (PAR-25-267)
  Application due date: Multiple dates, see announcement.
• Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required) (PAR-25-268)
  Application due date: Multiple dates, see announcement.
• Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required)(PAR-25-274)
  Application due date: Multiple dates, see announcement.
• Screening, Brief Intervention and Referral to Treatment or Prevention (SBIRT/P) for alcohol, tobacco, and other drugs (ATOD) use and misuse in adult populations that experience health disparities (R01, Clinical Trial Required) (PAR-26-001)
  Application due date: Multiple dates, see announcement.
• Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed) (RFA-DA-26-034)
  Application due date: Multiple dates, see announcement.
• BRAIN Initiative: Promoting Equity Through BRAIN Technology Partnerships (R34 - Clinical Trials Not Allowed) (RFA-NS-25-016)
  Application due date: Multiple dates, see announcement.

Other Funding News

General NIH notices:

• Reminder: FORMS-I Grant Application Forms and Instructions Must be Used for Due Dates On or After January 25, 2025 (NOT-OD-25-026)
• Reminder that Multiple Changes Affecting Extramural Applications and Review are Coming for Application Due Dates on or After January 25, 2025 (NOT-OD-25-035)

Notices of changes to NIH funding opportunities:

• Notice of Early Expiration of "Notice of Special Interest (NOSI): Advancing Research Needed to Develop a Universal Influenza Vaccine", NOT-AI-22-013 (NOT-AI-24-084)
• Notice of Early Expiration of "Notice of Special Interest (NOSI): Accelerating Malaria Vaccine Discovery", NOT-AI-22-014 (NOT-AI-24-086)
• Notice of Early Expiration of "Notice of Special Interest (NOSI): Leveraging Microbial Exposure for Improving Mouse Models of Human Immunity", NOT-AI-21-072 (NOT-AI-25-001)
• Notice to Extend the Response Date for NOT-DK-24-026, "Request for Information (RFI): Research Strategies for Addressing Obesity Heterogeneity" (NOT-DK-25-006)
• Notice of Early Expiration of PAR-22-137, Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R01-Clinical Trial Not Allowed) (NOT-MH-25-075)
• Notice of Early Expiration of PAR-22-138, "Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R21-Clinical Trial Not Allowed)" (NOT-MH-25-076)

Notices of intent to publish funding opportunities:

• Funding Opportunity for Biomarkers of Cognitive Decline and Dementias of Aging in Individuals within the Autism Spectrum (U01 Clinical Trial Optional) (NOT-AG-24-082)
• Funding Opportunity Announcement for NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use: Novel Approaches to Address HIV Related Health Disparities in Underserved Racial and/or Ethnic Populations (R34) (NOT-DA-24-051)
• Funding Opportunity Announcement for NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use: Novel Approaches to Address HIV Related Health Disparities in Underserved Racial and/or Ethnic Populations (R01) (NOT-DA-24-052)
• Funding Opportunity Announcement for Continuation of the NIDDK Hematology Central Coordinating Center (U24 Clinical Trial Not Allowed) (NOT-DK-24-032)
• Funding Opportunity Announcement for NINR Areas of Emphasis for Research to Optimize Health for All (R01 Clinical Trial Optional) (NOT-NR-25-006)
• Funding Opportunity Announcement for NINR Areas of Emphasis for Research to Optimize Health for All (R21 Clinical Trial Optional) (NOT-NR-25-007)

NIH Notices of Special Interest (NOSIs):

• Accelerating Malaria Vaccine and Monoclonal Antibody Discovery (NOT-AI-24-072)
  Expiration date: November 17, 2027
  
• Leveraging Microbial Exposure for Improving Mouse Models of Human Immunity (NOT-AI-24-078)
  Expiration date: November 17, 2027
  
• Advancing Research Needed to Develop a Universal Influenza Vaccine (NOT-AI-24-081)
  Expiration date: November 17, 2027
  

Non-NIH funding opportunities:

• The Make Our Planet Great Again (MOPGA) initiative are seeking at least 60 early career researchers wishing to carry out their research in France. Eligible research themes include: Earth systems, Climate change and sustainability, energy transition, Societal challenges of environmental issues and Human, animal and ecosystem health as part as a "One Health" approach.
  Application deadline: December 5, 2024

More non-NIH funding opportunities

Training Opportunities

Cornell Accepting Applications for Global Women’s Health Training

Applications are now open for the Global Infectious Diseases across a Woman's Lifespan Course, and the Women’s Infectious Diseases in Global Health Scholars (WINGS) Program. 

• Applications due: January 31, 2025
• Apply here
  

Manuscript, Abstract & Poster Submission Opportunities

• The Pan African Medical Journal is welcoming papers for a special edition related to all aspects of mpox in Africa, including epidemiology, research, clinical practice, outbreak investigation and response, and other relevant mpox data and activities in Africa.
  • Submissions due: November 30, 2024
• The Research for Health in Humanitarian Crises (R2HC) Forum will be a 3-day event, held in Nairobi, Kenya between 7-9 May 2025, and co-hosted with the African Population Health Research Center (APHRC). Elrha is inviting humanitarian health research, policy, and practice experts, with experience relevant to the key objectives and themes of the Forum, to contribute to making it a stimulating, engaging, and inclusive event.
  • Submissions due: December 15, 2024
• The International Cancer Screening Network (ICSN) is now accepting abstract submissions for ICSN 2025, which will be held June 18-20, 2025 in Aarhus, Denmark. The theme of ICSN 2025 is "Shaping the Future of Cancer Screening." Submitters are encouraged to submit abstracts that explore topics relating to one of the 10 abstracts themes.
  • Submissions due: January 2, 2025
• The National Cancer Institute is now accepting proposals for the annual ASGCR Symposium on Global Cancer Research. The theme of this year’s symposium is New Models for Participatory Research in Global Oncology: Elevating the Voices of Patients and Providers.
  • Symposium dates: May 5-8, 2025
  • Submissions due: January 17, 2025
• The Abstract Submission portal for INTEREST 2025, being held May 13-16, 2025, in Windhoek, Namibia, is now open. Successful candidates will be invited for an oral, mini-oral, or poster presentation.
  • Submissions due: January 17, 2025
• The Beyond Global Health (BGH) is interested in how people from the Global North and Global South to share their understanding of the concept of “Global Health.” Rather than exploring this through scientific journals and manuscripts, BGH is looking to expand on this idea through poetry, art, prose, and photography. Submissions are currently being accepted through the BGH website from researchers, participants, global health professionals, recipients of global health interventions, and anyone passionate about global health.
  • Submissions due: February 17, 2025

Events

Events for global health researchers:

• International Conference on Public Health in Africa

  • Date: November 26–29
  • Location: Rabat, Morocco
  • Hosted by the Africa CDC

Fogarty calendar of events